QQQ   444.02 (-0.36%)
AAPL   175.10 (-2.54%)
MSFT   414.92 (-0.14%)
META   498.19 (-0.82%)
GOOGL   133.35 (-2.76%)
AMZN   177.58 (-0.36%)
TSLA   188.14 (-7.16%)
NVDA   852.37 (+3.60%)
NIO   5.35 (-7.44%)
AMD   205.36 (+1.34%)
BABA   72.00 (-3.51%)
T   16.80 (-1.06%)
F   12.74 (+2.33%)
MU   95.77 (+0.65%)
CGC   3.02 (-5.92%)
GE   161.04 (+1.51%)
DIS   113.69 (+1.55%)
AMC   4.32 (-0.92%)
PFE   25.89 (-2.63%)
PYPL   59.98 (-0.93%)
XOM   104.36 (-1.40%)
QQQ   444.02 (-0.36%)
AAPL   175.10 (-2.54%)
MSFT   414.92 (-0.14%)
META   498.19 (-0.82%)
GOOGL   133.35 (-2.76%)
AMZN   177.58 (-0.36%)
TSLA   188.14 (-7.16%)
NVDA   852.37 (+3.60%)
NIO   5.35 (-7.44%)
AMD   205.36 (+1.34%)
BABA   72.00 (-3.51%)
T   16.80 (-1.06%)
F   12.74 (+2.33%)
MU   95.77 (+0.65%)
CGC   3.02 (-5.92%)
GE   161.04 (+1.51%)
DIS   113.69 (+1.55%)
AMC   4.32 (-0.92%)
PFE   25.89 (-2.63%)
PYPL   59.98 (-0.93%)
XOM   104.36 (-1.40%)
QQQ   444.02 (-0.36%)
AAPL   175.10 (-2.54%)
MSFT   414.92 (-0.14%)
META   498.19 (-0.82%)
GOOGL   133.35 (-2.76%)
AMZN   177.58 (-0.36%)
TSLA   188.14 (-7.16%)
NVDA   852.37 (+3.60%)
NIO   5.35 (-7.44%)
AMD   205.36 (+1.34%)
BABA   72.00 (-3.51%)
T   16.80 (-1.06%)
F   12.74 (+2.33%)
MU   95.77 (+0.65%)
CGC   3.02 (-5.92%)
GE   161.04 (+1.51%)
DIS   113.69 (+1.55%)
AMC   4.32 (-0.92%)
PFE   25.89 (-2.63%)
PYPL   59.98 (-0.93%)
XOM   104.36 (-1.40%)
QQQ   444.02 (-0.36%)
AAPL   175.10 (-2.54%)
MSFT   414.92 (-0.14%)
META   498.19 (-0.82%)
GOOGL   133.35 (-2.76%)
AMZN   177.58 (-0.36%)
TSLA   188.14 (-7.16%)
NVDA   852.37 (+3.60%)
NIO   5.35 (-7.44%)
AMD   205.36 (+1.34%)
BABA   72.00 (-3.51%)
T   16.80 (-1.06%)
F   12.74 (+2.33%)
MU   95.77 (+0.65%)
CGC   3.02 (-5.92%)
GE   161.04 (+1.51%)
DIS   113.69 (+1.55%)
AMC   4.32 (-0.92%)
PFE   25.89 (-2.63%)
PYPL   59.98 (-0.93%)
XOM   104.36 (-1.40%)

Omega Therapeutics (OMGA) Short Interest Ratio & Short Volume

$4.14
-0.16 (-3.72%)
(As of 03/4/2024 ET)

Omega Therapeutics Short Interest Data

Current Short Volume
3,310,000 shares
Previous Short Volume
3,130,000 shares
Change Vs. Previous Month
+5.75%
Dollar Volume Sold Short
$14.07 million
Short Interest Ratio / Days to Cover
1.6
Last Record Date
February 15, 2024
Outstanding Shares
55,140,000 shares
Float Size
20,420,000 shares
Short Percent of Float
16.21%
Today's Trading Volume
356,565 shares
Average Trading Volume
3,031,625 shares
Today's Volume Vs. Average
12%
cover of A Guide to High-Short-Interest Stocks and How to Trade Them ebook
Short Selling Omega Therapeutics ?

Sign up to receive the latest short interest report for Omega Therapeutics and its competitors with MarketBeat's FREE newsletter.

Skip Charts & View Short Interest History

OMGA Short Interest Over Time

OMGA Days to Cover Over Time

OMGA Percentage of Float Shorted Over Time


Omega Therapeutics Short Interest History

Report DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date
2/15/20243,310,000 shares $14.07 million +5.8%16.2%1.6 $4.25
1/31/20243,130,000 shares $11.42 million -13.5%14.7%1.6 $3.65
1/15/20243,620,000 shares $15.75 million +138.2%17.0%1.9 $4.35
12/31/20231,520,000 shares $4.58 million +2.7%7.1%0.9 $3.01
12/15/20231,480,000 shares $3.66 million -11.9%6.9%5.9 $2.47
11/30/20231,680,000 shares $3.85 million +0.6%7.9%7.5 $2.29
11/15/20231,670,000 shares $3.11 million -13.0%7.8%8.6 $1.86
10/31/20231,920,000 shares $2.63 million -6.8%9.0%10.3 $1.37
10/15/20232,060,000 shares $3.61 million +7.9%9.7%14 $1.75
9/30/20231,910,000 shares $4.11 million -11.2%9.0%13.8 $2.15
9/15/20232,150,000 shares $7.10 million +4.9%10.1%12.9 $3.30
8/31/20232,050,000 shares $7.52 million +12.6%9.6%11.9 $3.67
8/15/20231,820,000 shares $6.30 million +4.0%8.6%10.5 $3.46
7/31/20231,750,000 shares $9.78 million +7.4%8.2%10.2 $5.59
7/15/20231,630,000 shares $7.53 million +15.6%7.6%9.9 $4.62
6/30/20231,410,000 shares $7.90 million +33.0%6.6%8.8 $5.60
6/15/20231,060,000 shares $8.43 million +1.0%5.0%7 $7.95
5/31/20231,050,000 shares $7.97 million +8.2%6.4%10.4 $7.59
5/15/2023970,900 shares $8.23 million -1.9%6.7%10.3 $8.48
4/30/2023989,900 shares $7.58 million +7.2%6.5%10.5 $7.66
4/15/2023923,600 shares $6.98 million +34.0%6.0%10.2 $7.56
3/31/2023689,300 shares $4.16 million +65.1%4.5%7.2 $6.03
3/15/2023417,600 shares $2.83 million +10.8%2.7%5.2 $6.78
2/28/2023376,800 shares $2.43 million -5.0%2.2%5.9 $6.46
2/15/2023396,800 shares $2.20 million +14.3%2.0%6.6 $5.55
1/31/2023347,200 shares $2.73 million +6.3%2.0%6.1 $7.85
1/15/2023326,600 shares $2.83 million +3.5%1.8%6.6 $8.65
12/30/2022315,700 shares $1.80 million +0.1%1.8%8.2 $5.71
12/15/2022315,500 shares $1.92 million -3.9%1.8%7.3 $6.10
11/30/2022328,300 shares $2.30 million -6.4%1.9%5 $7.00
11/15/2022350,800 shares $2.17 million -6.7%2.0%5.4 $6.20
10/31/2022375,900 shares $1.81 million +2.2%2.1%5.2 $4.81
10/15/2022368,000 shares $1.69 million +15.0%2.1%4.7 $4.60
9/30/2022320,100 shares $1.73 million +15.3%1.8%3.8 $5.42
9/15/2022277,600 shares $1.71 million -14.0%1.6%2 $6.17
8/31/2022322,900 shares $1.44 million -13.6%1.8%2.4 $4.47
8/15/2022373,900 shares $1.87 million -14.9%2.1%2.3 $5.00
7/31/2022439,400 shares $2.24 million -18.5%2.5%2.5 $5.10
7/15/2022538,800 shares $2.32 million -24.3%3.1%2.8 $4.31
6/30/2022711,900 shares $2.71 million -37.0%4.1%3.6 $3.80













OMGA Short Interest - Frequently Asked Questions

What is Omega Therapeutics' current short interest?

Short interest is the volume of Omega Therapeutics shares that have been sold short but have not yet been closed out or covered. As of February 15th, traders have sold 3,310,000 shares of OMGA short. 16.21% of Omega Therapeutics' shares are currently sold short. Learn More on Omega Therapeutics' current short interest.

What is a good short interest ratio for Omega Therapeutics?

The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. OMGA shares currently have a short interest ratio of 2.0. Learn More on Omega Therapeutics's short interest ratio.

Which institutional investors are shorting Omega Therapeutics?

As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of Omega Therapeutics: Citadel Advisors LLC, Concourse Financial Group Securities Inc., and Simplex Trading LLC. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission.

What is a good short interest percentage for Omega Therapeutics?

Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 16.21% of Omega Therapeutics' floating shares are currently sold short.

Is Omega Therapeutics' short interest increasing or decreasing?

Omega Therapeutics saw a increase in short interest in the month of February. As of February 15th, there was short interest totaling 3,310,000 shares, an increase of 5.8% from the previous total of 3,130,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

What is Omega Therapeutics' float size?

Omega Therapeutics currently has issued a total of 55,140,000 shares. Some of Omega Therapeutics' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Omega Therapeutics currently has a public float of 20,420,000 shares.

How does Omega Therapeutics' short interest compare to its competitors?

16.21% of Omega Therapeutics' shares are currently sold short. Here is how the short interest of companies in the sector of "medical" compare to Omega Therapeutics: Jasper Therapeutics, Inc. (2.65%), Acumen Pharmaceuticals, Inc. (1.64%), Compugen Ltd. (2.42%), Century Therapeutics, Inc. (7.70%), Compass Therapeutics, Inc. (2.59%), INmune Bio, Inc. (9.97%), Fennec Pharmaceuticals Inc (8.93%), Ocugen, Inc. (9.50%), Mesoblast Limited (0.54%), Opthea Limited (0.27%),

Which stocks are the most shorted right now?

As of the most recent reporting period, the following stocks had the largest short interest positions: Super Micro Computer, Inc. ($5.32 billion), T-Mobile US, Inc. ($4.38 billion), General Motors ($3.76 billion), Occidental Petroleum Co. ($3.08 billion), Charter Communications, Inc. ($2.65 billion), Coinbase Global, Inc. ($2.62 billion), Tractor Supply ($2.52 billion), Moderna, Inc. ($2.19 billion), Rivian Automotive, Inc. ($1.84 billion), and Royal Caribbean Cruises Ltd. ($1.78 billion). View all of the most shorted stocks.

What does it mean to sell short Omega Therapeutics stock?

Short selling OMGA is an investing strategy that aims to generate trading profit from Omega Therapeutics as its price is falling. OMGA shares are trading down $0.16 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

How does a short squeeze work against Omega Therapeutics?

A short squeeze for Omega Therapeutics occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of OMGA, which in turn drives the price of the stock up even further.

How often is Omega Therapeutics' short interest reported?

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including OMGA, twice per month. The most recent reporting period available is February, 15 2024.



More Short Interest Resources from MarketBeat

This page (NASDAQ:OMGA) was last updated on 3/4/2024 by MarketBeat.com Staff